A close adherence to a stoma-therapeutic pathway improves immediate stoma-related outcomes and reduces the length of hospital stay

Purpose New stoma creation is related to a wide range of implications and stoma-related complications could occur frequently. The aim was to assess the impact of a close stoma-therapeutic-care pathway (STCP) in terms of length of stay, autonomy in the management of the pouch, readmission rate, and stoma-related complications. Methods Patients undergoing surgery for colorectal disease and first stoma creation from January 2017 to December 2020 were analyzed. All patients enrolled had joined the Enhanced Recovery after Surgery (ERAS) protocol. Results Among 143 enrolled, 56 (40%) did not completely follow the STCP (group A), whereas 87 (60%) demonstrated strict compliance (group B). The hospital stay lasted 8 days in group B and 11.5 in group A ( p = 0.001). The first look at the stoma needed 1 day in group B and 3 days in group A ( p < 0.001), emptying the pouch 2 days in group B and 5 days in group A ( p < 0.001). Finally, the ability to change the pouch was 3 days in group B and 6 days in group A ( p < 0.001). Nine (16.1%) stoma-related complications were counted in group A and 16 (18.4%) in group B, and 30-day readmission was 10.1% in group B and 11.5% in group A ( p = 0.82 and p = 1, respectively, not significant). Conclusions The STCP has been shown to reduce the hospital stay and to have a protective role making the patient autonomous in the management of the stoma.